Risk Minimisation Materials

Tenofovir Disoproxil Fumarate (TDF)) HIV Paediatric Educational Brochure

Brochure providing important advice on the management of potential renal and bone effects of TDF in children and adolescent patients with HIV-1 aged 2 to <18 years, and on the dosing recommendations for TDF in this population.

For Healthcare Professionals